Search for: "Director of Patent and Trademark Office"
Results 101 - 120
of 2,891
Sort by Relevance
|
Sort by Date
19 Sep 2023, 8:35 pm
Patent and Trademark Office (USPTO) Director Kathi Vidal during a lunchtime fireside chat with IPWatchdog Founder and CEO Gene Quinn on Day 3 of IPWatchdog LIVE 2023. [read post]
18 Sep 2023, 11:15 am
Patent and Trademark Office (USPTO) Acting Director and Acting Solicitor; and Eli Mazour of Harrity & Harrity. [read post]
18 Sep 2023, 11:15 am
Patent and Trademark Office (USPTO) Acting Director and Acting Solicitor; and Eli Mazour of Harrity & Harrity. [read post]
14 Sep 2023, 9:15 am
Patent and Trademark Office (USPTO) Director Kathi Vidal sua sponte ordered Director Review of PTAB’s sanctions order. [read post]
14 Sep 2023, 9:15 am
Patent and Trademark Office (USPTO) Director Kathi Vidal sua sponte ordered Director Review of PTAB’s sanctions order. [read post]
13 Sep 2023, 3:15 pm
Patent and Trademark Office (USPTO) Director Kathi Vidal’s petition to the U.S. [read post]
13 Sep 2023, 3:15 pm
Patent and Trademark Office (USPTO) Director Kathi Vidal’s petition to the U.S. [read post]
13 Sep 2023, 6:22 am
The United States Patent and Trademark Office (USPTO) has introduced a new Patents Petitions webpage to provide improved service to patent owners and applicants seeking agency action. [read post]
31 Aug 2023, 10:00 am
On July 24, 2023, the United States Patent and Trademark Office changed its procedures for the PTO Director’s review of certain decisions by the Patent Trial and Appeal Board. [read post]
30 Aug 2023, 11:30 pm
Read the full story here USPTO updates Director Review powers and procedures Based on feedback received from stakeholders, the United States Patent and Trademark Office (USPTO) improved and streamlined the processes related to interim Director Review (DR) of Patent Trial and Appeal Board (PTAB) decisions with effect from 24 July 2023. [read post]
21 Aug 2023, 11:15 am
Patent and Trademark Office (USPTO) hosted a webinar to discuss recent revisions to the interim process for Director review of America Invents Act (AIA) trial decisions by the Patent Trial and Appeal Board (PTAB). [read post]
21 Aug 2023, 11:15 am
Patent and Trademark Office (USPTO) hosted a webinar to discuss recent revisions to the interim process for Director review of America Invents Act (AIA) trial decisions by the Patent Trial and Appeal Board (PTAB). [read post]
21 Aug 2023, 1:20 am
The UK IPO, which is the country's patent and trademark office, correctly notes that SEP licensing is a field in which any potential intervention must be approached with caution, which contrasts nicely with the regulatory activism exhibited by the European Commission's Directorate-General for the Internal Market (DG GROW). [read post]
11 Aug 2023, 10:51 am
Patent & Trademark Office (“USPTO”). [read post]
10 Aug 2023, 10:25 am
We do not handle patents. [read post]
9 Aug 2023, 12:29 pm
We announced a new Trademarks for Humanity Awards Program, Patents for Humanity Green Energy category, and partnership with the World Intellectual Property Organization’s WIPO GREEN Program. [read post]
29 Jul 2023, 2:17 am
For Targets with significant patents, trademarks and other intellectual property, the Buyer will sometimes engage a specialist consultant to help with analysis of such intellectual property. [read post]
26 Jul 2023, 10:00 pm
The US Patent and Trademark Office (USPTO) recently issued an update to its procedures for interim Director Review (DR) of decisions by the Patent Trial and Appeal Board (PTAB), evidencing USPTO Director Kathi Vidal’s efforts to formalize the process and procedures for conducting DRs following the US Supreme Court’s Arthrex decision. [read post]
26 Jul 2023, 10:00 pm
The US Patent and Trademark Office (USPTO) recently issued an update to its procedures for interim Director Review (DR) of decisions by the Patent Trial and Appeal Board (PTAB), evidencing USPTO Director Kathi Vidal’s efforts to formalize the process and procedures for conducting DRs following the US Supreme Court’s Arthrex decision. [read post]
26 Jul 2023, 10:00 pm
The US Patent and Trademark Office (USPTO) recently issued an update to its procedures for interim Director Review (DR) of decisions by the Patent Trial and Appeal Board (PTAB), evidencing USPTO Director Kathi Vidal’s efforts to formalize the process and procedures for conducting DRs following the US Supreme Court’s Arthrex decision. [read post]
